(VIANEWS) – Golden Bull Limited (BTBT), Virtu Financial (VIRT), United Therapeutics Corporation (UTHR) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Golden Bull Limited (BTBT)
188.2% sales growth and 21.83% return on equity
Bit Digital, Inc., together with its subsidiaries, engages in the bitcoin mining business. It is also involved in the treasury management activities; and digital asset staking and digital asset mining businesses, as well as ethereum staking activities. The company was formerly known as Golden Bull Limited and changed its name to Bit Digital, Inc. in September 2020. Bit Digital, Inc. was founded in 2015 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, Golden Bull Limited has a trailing twelve months EPS of $0.3.
PE Ratio
Golden Bull Limited has a trailing twelve months price to earnings ratio of 9.8. Meaning, the purchaser of the share is investing $9.8 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.83%.
Sales Growth
Golden Bull Limited’s sales growth is 188.7% for the ongoing quarter and 188.2% for the next.
Moving Average
Golden Bull Limited’s worth is under its 50-day moving average of $3.26 and higher than its 200-day moving average of $2.80.
Volume
Today’s last reported volume for Golden Bull Limited is 11591900 which is 1.84% above its average volume of 11382500.
2. Virtu Financial (VIRT)
35.1% sales growth and 24.4% return on equity
Virtu Financial, Inc., together with its subsidiaries, provides market making and liquidity services through its proprietary, multi-asset, and multi-currency technology platform to the financial markets worldwide. The company's Market Making segment principally consists of market making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Its Execution Services segment comprises agency-based trading and trading venues, which offer execution services in equities, ETFs, futures, fixed income, currencies, and commodities to institutions, banks, and broker dealers. Virtu Financial, Inc. was founded in 2008 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, Virtu Financial has a trailing twelve months EPS of $1.99.
PE Ratio
Virtu Financial has a trailing twelve months price to earnings ratio of 13.99. Meaning, the purchaser of the share is investing $13.99 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.4%.
Moving Average
Virtu Financial’s worth is way higher than its 50-day moving average of $24.11 and way higher than its 200-day moving average of $20.53.
Yearly Top and Bottom Value
Virtu Financial’s stock is valued at $27.85 at 20:22 EST, below its 52-week high of $29.69 and way higher than its 52-week low of $16.02.
3. United Therapeutics Corporation (UTHR)
18.7% sales growth and 19.25% return on equity
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin, an infused formulation of the prostacyclin analogue treprostinil for subcutaneous and intravenous administration to diminish symptoms associated with exercise in pulmonary arterial hypertension (PAH) patients; Tyvaso, an inhaled formulation of treprostinil to enhance the exercise ability in PAH patients; Orenitram, a tablet dosage form of treprostinil to enhance the exercise capacity in PAH patients; Unituxin, a monoclonal antibody for treating high-risk neuroblastoma; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. The company also engages in developing OreniPro, RemoPro, Tyvaso DPI, Trevyent, Ralinepag, and Aurora-GT to treat PAH; Unexisome to treat bronchopulmonary dysplasia; and the research and development of various organ transplantation-related technologies, including regenerative medicine, xenotransplantation, and ex-vivo lung perfusion, as well as the development of medicine for other diseases. It has licensing and collaboration agreements with Medtronic, Inc. to develop and commercialize the implantable system for Remodulin; Caremark, L.L.C. to provide refills of implanted pumps at its infusion centers; DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of Remodulin; MannKind Corporation to develop and license treprostinil inhalation powder and Dreamboat devices; and Arena Pharmaceuticals, Inc. to develop ralinepag for the treatment of PAH. The company was incorporated in 1996 and is headquartered in Silver Spring, Maryland.
Earnings Per Share
As for profitability, United Therapeutics Corporation has a trailing twelve months EPS of $21.76.
PE Ratio
United Therapeutics Corporation has a trailing twelve months price to earnings ratio of 14.75. Meaning, the purchaser of the share is investing $14.75 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.25%.
4. Esquire Financial Holdings (ESQ)
16.1% sales growth and 20.32% return on equity
Esquire Financial Holdings, Inc. operates as the bank holding company for Esquire Bank, National Association that provides commercial banking products and services to legal industry and small businesses, and commercial and retail customers in the United States. The company offers checking, savings, money market, and time deposits, as well as certificates of deposit. It also provides commercial loans, including short-term financing for inventory, receivables, the purchase of supplies, or other operating needs arising during the normal course of business, as well as loans to its qualified merchant customers; commercial lines of credit; consumer loans consisting of post-settlement consumer and structured settlement loans to plaintiffs and claimants, as well as loans to individuals for debt consolidation, medical expenses, living expenses, payment of outstanding bills, or other consumer needs; and real estate loans, such as multifamily, 1-4 family residential, commercial real estate, and construction loans, as well as merchant services. As of December 31, 2020, the company operated a full-service branch in Jericho, New York; and an administrative office in Boca Raton, Florida. Esquire Financial Holdings, Inc. was founded in 2006 and is headquartered in Jericho, New York.
Earnings Per Share
As for profitability, Esquire Financial Holdings has a trailing twelve months EPS of $4.79.
PE Ratio
Esquire Financial Holdings has a trailing twelve months price to earnings ratio of 12.11. Meaning, the purchaser of the share is investing $12.11 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.32%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 12% and 15.3%, respectively.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Aug 15, 2024, the estimated forward annual dividend rate is 0.6 and the estimated forward annual dividend yield is 1.05%.
5. Ryder System (R)
11.4% sales growth and 16.06% return on equity
Ryder System, Inc. operates as a logistics and transportation company worldwide. It operates through three segments: Fleet Management Solutions (FMS), Supply Chain Solutions (SCS), and Dedicated Transportation Solutions (DTS). The FMS segment offers full-service leasing and leasing with flexible maintenance options; commercial vehicle rental services; and contract or transactional maintenance services of trucks, tractors, and trailers; access to diesel fuel; and fuel planning and tax reporting, cards, and monitoring services, and centralized billing, as well as sells used vehicles through its retail sales centers and www.ryder.com/used-trucks website, as well as digital and technology support services. The DTS segment offers equipment, maintenance, drivers, administrative, and additional services, as well as routing and scheduling, fleet sizing, safety, regulatory compliance, risk management, and technology and communication systems support services. The SCS segment comprises distribution management services, such as designing and managing customer's distribution network and facilities; coordinating warehousing and transportation for inbound and outbound material flows; handling import and export for international shipments; coordinating just-in-time replenishment of component parts to manufacturing and final assembly; and offering shipments to customer distribution centers or end customer delivery points, as well as other value added services, such as light assembly of components. This segment also offers transportation management and brokerage services, such as shipment optimization, load scheduling, and delivery confirmation services; knowledge-based professional services; and e-commerce and last mile services. The company was founded in 1933 and is headquartered in Coral Gables, Florida.
Earnings Per Share
As for profitability, Ryder System has a trailing twelve months EPS of $10.85.
PE Ratio
Ryder System has a trailing twelve months price to earnings ratio of 12.31. Meaning, the purchaser of the share is investing $12.31 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.06%.
Sales Growth
Ryder System’s sales growth is 12.7% for the current quarter and 11.4% for the next.
Yearly Top and Bottom Value
Ryder System’s stock is valued at $133.56 at 20:22 EST, under its 52-week high of $143.54 and way higher than its 52-week low of $91.31.
6. Tetra Tech (TTEK)
10.7% sales growth and 18.66% return on equity
Tetra Tech, Inc. provides consulting and engineering services worldwide. The company operates through Government Services Group (GSG) and Commercial/International Services Group (CIG) segments. The GSG segment offers early data collection and monitoring, data analysis and information technology, science and engineering applied research, engineering design, construction management, and operations and maintenance services; and climate change and energy management consulting, as well as greenhouse gas inventory assessment, certification, reduction, and management services. This segment serves federal, state, and local governments, and development agencies in water resources analysis and water management, environmental monitoring, data analytics, government consulting, waste management, and a range of civil infrastructure master planning and engineering design markets. The CIG segment provides early data collection and monitoring, data analysis and information management, feasibility studies and assessments, science and engineering applied research, engineering design, construction management, and operations and maintenance services. This segment serves natural resources, energy, and utilities markets, as well as civil infrastructure master planning and engineering design markets. Tetra Tech, Inc. was founded in 1966 and is headquartered in Pasadena, California.
Earnings Per Share
As for profitability, Tetra Tech has a trailing twelve months EPS of $5.4.
PE Ratio
Tetra Tech has a trailing twelve months price to earnings ratio of 42.41. Meaning, the purchaser of the share is investing $42.41 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.66%.
Volume
Today’s last reported volume for Tetra Tech is 148752 which is 50.19% below its average volume of 298674.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 3.9% and 17.9%, respectively.
Moving Average
Tetra Tech’s value is above its 50-day moving average of $211.92 and way higher than its 200-day moving average of $187.21.
7. Crexendo (CXDO)
9.1% sales growth and 6.24% return on equity
Crexendo, Inc. provides cloud communication platform and services, video collaboration, and managed IT services for businesses in the United States, Canada, and internationally. It operates through two segments, Cloud Telecommunications and Software Solutions. The Cloud Telecommunications segment provides telecommunications services that transmit calls using Internet protocol (IP) or cloud technology, which converts voice signals into digital data packets for transmission over the Internet or cloud; and broadband Internet services. This segment is also involved in the sale and lease of cloud telecommunications equipment. In addition, it offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over high-speed internet connection through various devices and user interfaces, such as desktop phones and/or mobile, and desktop applications under the Crexendo brand name. The Software Solutions segment provides suite of unified communications, video conferencing, collaboration, and contact center solutions. This segment also offers SNAPsolution, a IP-based platform; and SNAPaccel, a software-as-a-service based software, as well as provides subscription maintenance and support, and professional services, including consulting, technical support, resident engineer, design, and installation services. The company was formerly known as iMergent, Inc. and changed its name to Crexendo, Inc. in May 2011. Crexendo, Inc. was incorporated in 1995 and is based in Tempe, Arizona.
Earnings Per Share
As for profitability, Crexendo has a trailing twelve months EPS of $0.1.
PE Ratio
Crexendo has a trailing twelve months price to earnings ratio of 52.9. Meaning, the purchaser of the share is investing $52.9 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.24%.
Moving Average
Crexendo’s worth is way above its 50-day moving average of $3.71 and way higher than its 200-day moving average of $4.23.
